dabigatran has been researched along with tacrolimus in 1 studies
Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
---|---|---|---|---|---|
3,887 | 261 | 3,490 | 17,757 | 2,319 | 6,661 |
Protein | Taxonomy | dabigatran (IC50) | tacrolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 7.18 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bender, J; Bryant, G; Koenigsfeld, C; Lehman, N; Logemann, C; Sayler, M | 1 |
1 other study(ies) available for dabigatran and tacrolimus
Article | Year |
---|---|
Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx?
Topics: Aged; Antithrombins; Atrial Fibrillation; Conjunctival Diseases; Dabigatran; Drug Interactions; Drug Substitution; Eye Hemorrhage; Female; Humans; Immunosuppressive Agents; International Normalized Ratio; Liver Transplantation; Renal Insufficiency; Tacrolimus; Treatment Outcome | 2015 |